|

ATG 4.0 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Instituto Nacional de Cancer, Brazil1

Indications

  • Hodgkin Lymphoma1
  • Non-hodgkin Lymphoma1
  • Acute Myeloid Leukemia1
  • Acute Lymphoblastic Leukemia1
  • Myelodysplastic Syndromes1

Other1 trial

PTCy and ATG for MSD and MUD Transplants
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.